SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-035144
Filing Date
2020-11-05
Accepted
2020-11-05 07:11:56
Documents
14
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea129358-8k_intecpharma.htm   iXBRL 8-K 35127
2 PRESS RELEASE, DATED NOVEMBER 5, 2020 ea129358ex99-1_intec.htm EX-99.1 144577
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3100
  Complete submission text file 0001213900-20-035144.txt   374746

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ntec-20201105.xsd EX-101.SCH 3185
5 XBRL LABEL FILE ntec-20201105_lab.xml EX-101.LAB 34559
6 XBRL PRESENTATION FILE ntec-20201105_pre.xml EX-101.PRE 22706
7 EXTRACTED XBRL INSTANCE DOCUMENT ea129358-8k_intecpharma_htm.xml XML 3733
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37521 | Film No.: 201288643
SIC: 2834 Pharmaceutical Preparations